Scarica l'app Stockscreener
5.76
0.88%
0.05
Dopo l'orario di chiusura:
5.78
0.02
+0.35%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$5.71
Aprire:
$5.74
Volume 24 ore:
186.64K
Relative Volume:
0.55
Capitalizzazione di mercato:
$371.36M
Reddito:
-
Utile/perdita netta:
$-45.08M
Rapporto P/E:
-7.8904
EPS:
-0.73
Flusso di cassa netto:
$-33.68M
1 W Prestazione:
+0.35%
1M Prestazione:
+10.13%
6M Prestazione:
+350.00%
1 anno Prestazione:
+107.94%
Intervallo 1D:
$5.66
$5.85
Intervallo di 1 settimana:
$5.23
$6.1558
Portata 52W:
$0.726
$6.55
Galectin Therapeutics Inc Stock (GALT) Company Profile
Nome
Galectin Therapeutics Inc
Settore
Industria
Telefono
678-620-3186
Indirizzo
4960 PEACHTREE INDUSTRIAL BOULEVARD, NORCROSS, GA
Confronta GALT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GALT
Galectin Therapeutics Inc
|
5.76 | 368.14M | 0 | -45.08M | -33.68M | -0.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
432.17 | 109.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
784.61 | 82.75B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
445.24 | 56.78B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.63 | 56.52B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.51 | 44.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Galectin Therapeutics Inc Stock (GALT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-17 | Ripresa | H.C. Wainwright | Buy |
| 2020-08-13 | Reiterato | H.C. Wainwright | Buy |
| 2019-02-13 | Iniziato | B. Riley FBR | Buy |
| 2017-12-07 | Reiterato | H.C. Wainwright | Buy |
| 2017-11-28 | Reiterato | H.C. Wainwright | Buy |
| 2017-10-19 | Iniziato | ROTH Capital | Buy |
| 2017-03-30 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2016-10-03 | Downgrade | FBR & Co. | Outperform → Mkt Perform |
| 2016-09-29 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2016-09-28 | Downgrade | ROTH Capital | Buy → Sell |
| 2016-03-28 | Ripresa | H.C. Wainwright | Buy |
| 2015-09-21 | Iniziato | H.C. Wainwright | Buy |
| 2014-08-01 | Downgrade | Aegis Capital | Buy → Hold |
| 2014-07-30 | Reiterato | MLV & Co | Buy |
| 2014-07-29 | Reiterato | MLV & Co | Buy |
| 2014-04-02 | Reiterato | MLV & Co | Buy |
| 2014-02-10 | Reiterato | Aegis Capital | Buy |
| 2014-01-09 | Reiterato | Aegis Capital | Buy |
| 2013-12-03 | Iniziato | MLV & Co | Buy |
| 2013-08-19 | Reiterato | Aegis Capital | Buy |
Mostra tutto
Galectin Therapeutics Inc Borsa (GALT) Ultime notizie
Will Galectin Therapeutics Inc. stock sustain high P E ratiosTrade Volume Summary & Weekly High Potential Alerts - BỘ NỘI VỤ
Galectin Therapeutics: NAVIGATE Data Validates The Fibrosis Thesis - Seeking Alpha
Wealthspire Advisors LLC Buys 81,144 Shares of Galectin Therapeutics Inc. $GALT - MarketBeat
How Galectin Therapeutics Inc. stock reacts to Fed rate cutsDip Buying & Stepwise Trade Execution Plans - newser.com
How Galectin Therapeutics Inc. (PHPN) stock trades pre earnings2025 Support & Resistance & Fast Entry Momentum Trade Alerts - newser.com
What sentiment indicators say about Galectin Therapeutics Inc. stockTrade Analysis Summary & Real-Time Buy Zone Alerts - newser.com
Will Galectin Therapeutics Inc. (PHPN) stock beat international competitionTrade Entry Report & Verified Swing Trading Watchlist - newser.com
Can Galectin Therapeutics Inc. (PHPN) stock double in coming yearsBull Run & Technical Pattern Recognition Alerts - newser.com
Applying Elliott Wave Theory to Galectin Therapeutics Inc.Quarterly Profit Review & Step-by-Step Trade Execution Guides - newser.com
Will Galectin Therapeutics Inc. (PHPN) stock hit analyst forecasts2025 Institutional Moves & Breakout Confirmation Alerts - newser.com
Galectin Therapeutics Insider Sold Shares Worth $478,849, According to a Recent SEC Filing - MarketScreener
CFO Callicutt Sells 77,920 ($478.8K) Of Galectin Therapeutics Inc [GALT] - TradingView
CEO Lewis Sells 22,463 ($136.4K) Of Galectin Therapeutics Inc [GALT] - TradingView
[Form 4] GALECTIN THERAPEUTICS INC Insider Trading Activity - Stock Titan
What valuation multiples suggest for Galectin Therapeutics Inc. stock2025 Fundamental Recap & Consistent Profit Alerts - newser.com
Holdings of Galectin Therapeutics Inc (GALT) are aligned with the stars - Setenews
How robust is Galectin Therapeutics Inc. (PHPN) stock financial positionGap Up & Real-Time Buy Signal Alerts - newser.com
How big funds are accumulating Galectin Therapeutics Inc. (PHPN) stock2025 Macro Impact & Low Drawdown Investment Strategies - newser.com
Galectin Therapeutics (NASDAQ:GALT) Insider Sells 121,117 Shares - MarketBeat
Galectin Therapeutics (NASDAQ:GALT) Releases Earnings Results, Misses Estimates By $0.02 EPS - MarketBeat
Can you recover from losses in Galectin Therapeutics Inc.Weekly Stock Summary & Entry Point Confirmation Signals - newser.com
Galectin Therapeutics reports Q4 EPS (13c) vs (18c) last year - MSN
Will Galectin Therapeutics Inc. (PHPN) stock beat growth indexesWeekly Volume Report & Free AI Powered Buy and Sell Recommendations - newser.com
Galectin Therapeutics (NASDAQ:GALT) Stock Price Crosses Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Galectin Therapeutics Inc Azioni (GALT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Galectin Therapeutics Inc Azioni (GALT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| LEWIS JOEL | President and CEO |
Nov 18 '25 |
Option Exercise |
2.39 |
6,783 |
16,211 |
839,375 |
| LEWIS JOEL | President and CEO |
Nov 17 '25 |
Sale |
6.04 |
15,680 |
94,643 |
832,592 |
| LEWIS JOEL | President and CEO |
Nov 18 '25 |
Sale |
6.15 |
6,783 |
41,723 |
832,592 |
| CALLICUTT JACK W | Chief Financial Officer |
Nov 18 '25 |
Option Exercise |
1.64 |
46,310 |
75,851 |
35,714 |
| CALLICUTT JACK W | Chief Financial Officer |
Nov 17 '25 |
Option Exercise |
1.38 |
31,610 |
43,706 |
27,315 |
| CALLICUTT JACK W | Chief Financial Officer |
Nov 18 '25 |
Sale |
6.22 |
46,310 |
288,187 |
7,614 |
| CALLICUTT JACK W | Chief Financial Officer |
Nov 17 '25 |
Sale |
6.03 |
31,610 |
190,662 |
7,614 |
| Jamil Khurram | Chief Medical Officer |
Nov 13 '25 |
Option Exercise |
2.17 |
99,250 |
215,038 |
45,979 |
| Jamil Khurram | Chief Medical Officer |
Nov 13 '25 |
Sale |
5.47 |
121,117 |
662,510 |
4,479 |
0.76%
2.16%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):